Realizing the Potential of Anti–SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management
Jonathan Z. Li, Rajesh T. Gandhi
Abstract
Combination Casirivimab and Imdevimab and Development of Symptomatic COVID-19 in SARS-CoV-2 Infection
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyMonoclonal antibodyBetacoronavirusSars virusCoronavirus InfectionsAntibodyImmunologyInternal medicineInfectious disease (medical specialty)OutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19